Literature DB >> 15972487

Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli.

David A Hunstad1, Sheryl S Justice, Chia S Hung, Scott R Lauer, Scott J Hultgren.   

Abstract

Urinary tract infections are most commonly caused by uropathogenic strains of Escherichia coli (UPEC), which invade superficial bladder epithelial cells via a type 1 pilus-dependent mechanism. Inside these epithelial cells, UPEC organisms multiply to high numbers to form intracellular bacterial communities, allowing them to avoid immune detection. Bladder epithelial cells produce interleukin-6 (IL-6) and IL-8 in response to laboratory strains of E. coli in vitro. We investigated the ability of UPEC to alter epithelial cytokine signaling by examining the in vitro responses of bladder epithelial cell lines to the cystitis strains UTI89 and NU14. The cystitis strains induced significantly less IL-6 than did the laboratory E. coli strain MG1655 from 5637 and T24 bladder epithelial cells. The cystitis strains also suppressed epithelial cytokine responses to exogenous lipopolysaccharide (LPS) and to laboratory E. coli. We found that insertional mutations in the rfa and rfb operons and in the surA gene all abolished the ability of UTI89 to suppress cytokine induction. The rfa and rfb operons encode LPS biosynthetic genes, while surA encodes a periplasmic cis-trans prolyl isomerase important in the biogenesis of outer membrane proteins. We conclude that, in this in vitro model system, cystitis strains of UPEC have genes encoding factors that suppress proinflammatory cytokine production by bladder epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972487      PMCID: PMC1168571          DOI: 10.1128/IAI.73.7.3999-4006.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

1.  Crystallographic structure of SurA, a molecular chaperone that facilitates folding of outer membrane porins.

Authors:  Eduard Bitto; David B McKay
Journal:  Structure       Date:  2002-11       Impact factor: 5.006

Review 2.  Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection.

Authors:  C M Tato; C A Hunter
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

3.  Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.

Authors:  M A Mulvey; J D Schilling; S J Hultgren
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Lipopolysaccharides from periodontopathic bacteria Porphyromonas gingivalis and Capnocytophaga ochracea are antagonists for human toll-like receptor 4.

Authors:  Atsutoshi Yoshimura; Takashi Kaneko; Yoshifumi Kato; Douglas T Golenbock; Yoshitaka Hara
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

5.  Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB.

Authors:  D J Klumpp; A C Weiser; S Sengupta; S G Forrestal; R A Batler; A J Schaeffer
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Genetic evidence for parallel pathways of chaperone activity in the periplasm of Escherichia coli.

Authors:  A E Rizzitello; J R Harper; T J Silhavy
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

7.  Induction of innate immune responses by Escherichia coli and purified lipopolysaccharide correlate with organ- and cell-specific expression of Toll-like receptors within the human urinary tract.

Authors:  F Bäckhed; M Söderhäll; P Ekman; S Normark; A Richter-Dahlfors
Journal:  Cell Microbiol       Date:  2001-03       Impact factor: 3.715

8.  Il-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation.

Authors:  S M Hurst; T S Wilkinson; R M McLoughlin; S Jones; S Horiuchi; N Yamamoto; S Rose-John; G M Fuller; N Topley; S A Jones
Journal:  Immunity       Date:  2001-06       Impact factor: 31.745

9.  Localization of uroplakin Ia, the urothelial receptor for bacterial adhesin FimH, on the six inner domains of the 16 nm urothelial plaque particle.

Authors:  Guangwei Min; Martin Stolz; Ge Zhou; Fengxia Liang; Peter Sebbel; Daniel Stoffler; Rudi Glockshuber; Tung-Tien Sun; Ueli Aebi; Xiang-Peng Kong
Journal:  J Mol Biol       Date:  2002-04-12       Impact factor: 5.469

10.  Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the nuclear factor-kappa B pathway and exploits lipopolysaccharide signaling to trigger apoptosis in macrophages.

Authors:  K Ruckdeschel; O Mannel; K Richter; C A Jacobi; K Trülzsch; B Rouot; J Heesemann
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

View more
  62 in total

Review 1.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

Review 2.  Host-pathogen interactions in urinary tract infection.

Authors:  Greta R Nielubowicz; Harry L T Mobley
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 3.  TLR-mediated immune responses in the urinary tract.

Authors:  Jeongmin Song; Soman N Abraham
Journal:  Curr Opin Microbiol       Date:  2008-02-01       Impact factor: 7.934

4.  Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins.

Authors:  Travis J Wiles; Bijaya K Dhakal; Danelle S Eto; Matthew A Mulvey
Journal:  Mol Biol Cell       Date:  2008-01-30       Impact factor: 4.138

5.  Filamentation by Escherichia coli subverts innate defenses during urinary tract infection.

Authors:  Sheryl S Justice; David A Hunstad; Patrick C Seed; Scott J Hultgren
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-15       Impact factor: 11.205

6.  Molecular basis of uropathogenic Escherichia coli evasion of the innate immune response in the bladder.

Authors:  Benjamin K Billips; Anthony J Schaeffer; David J Klumpp
Journal:  Infect Immun       Date:  2008-06-16       Impact factor: 3.441

7.  OmpA of uropathogenic Escherichia coli promotes postinvasion pathogenesis of cystitis.

Authors:  Tracy F Nicholson; Kristin M Watts; David A Hunstad
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

8.  Cytotoxic necrotizing factor 1 and hemolysin from uropathogenic Escherichia coli elicit different host responses in the murine bladder.

Authors:  Tamako A Garcia; Christy L Ventura; Mark A Smith; D Scott Merrell; Alison D O'Brien
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

9.  In vivo gene expression analysis identifies genes required for enhanced colonization of the mouse urinary tract by uropathogenic Escherichia coli strain CFT073 dsdA.

Authors:  Brian J Haugen; Shahaireen Pellett; Peter Redford; Holly L Hamilton; Paula L Roesch; Rodney A Welch
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

10.  Lipopolysaccharide Domains Modulate Urovirulence.

Authors:  Lizath M Aguiniga; Ryan E Yaggie; Anthony J Schaeffer; David J Klumpp
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.